Comments
Dr Lal PathLabs on Thursday said its consolidated profit after tax declined 7 per cent to ₹54 crore for the December quarter.
The company had reported a net profit of ₹58 crore in the October-December quarter of the previous fiscal.
Revenue also declined to ₹489 crore for the period under review as compared with ₹497 crore in the year-ago period, the company said in a regulatory filing.
Also read: Britannia’s Q3 net profit up 151% to ₹932 crore on one-time exceptional gain
"We continue to focus on geographical expansion and strengthen our presence in Tier 2, Tier 3 towns. Our focus continues to take a higher market share in West and South markets by leveraging technology and promoting high-end super specialty test portfolios," Dr Lal PathLabs Managing Director Om Manchanda said.
Shares of the company were trading 1.63 per cent down at ₹2,019.15 apiece on the BSE.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.